Fact-checked by Grok 2 weeks ago

Functional electrical stimulation

Functional electrical stimulation (FES) is a technique that applies controlled electrical currents to nerves or muscles to elicit functional contractions, enabling purposeful movements in individuals with motor impairments due to conditions such as , (SCI), or . This method, a subset of neuromuscular electrical stimulation (NMES), targets paralyzed or weakened muscles to restore activities like grasping, walking, standing, or reaching, often through surface electrodes placed on the skin or implanted devices. By mimicking natural neural signals, FES produces coordinated muscle activation, with stimulation parameters typically including pulse frequencies of 20-50 Hz, amplitudes adjusted for motor thresholds, and durations of 200-400 microseconds to optimize force without excessive fatigue. The origins of FES trace back to the , when early experiments demonstrated its potential for generating functional movements in paralyzed limbs, evolving from basic neuromuscular stimulation into sophisticated neuroprosthetic systems by the 1980s and 1990s. Pioneering work by researchers like Kralj and colleagues advanced FES for restoration in patients, while subsequent developments integrated it with orthoses and sensors for closed-loop control, enhancing precision and user independence. Today, FES serves dual roles: as an orthotic device for immediate functional support, such as correcting during ambulation, and as a therapeutic intervention (FEST) that promotes and long-term motor recovery through repeated use. Applications of FES span upper and lower limb rehabilitation, respiratory support, and beyond, with clinical evidence showing improvements in walking speed, grasp strength, and for post- and populations. For instance, upper limb FES systems, often triggered by (EMG) or brain-computer interfaces (BCI), have demonstrated significant gains in Fugl-Meyer Assessment scores (mean difference up to 14 points) and Action Research Arm Test outcomes (mean difference up to 11.9 points) in survivors. In lower limb use, devices like the Bioness L300 System provide ankle dorsiflexion stimulation to reduce and enhance symmetry, while abdominal FES improves respiratory function in tetraplegic patients by augmenting . Emerging integrations with and wearable textiles further expand accessibility, though challenges like and comfort persist, driving ongoing research into adaptive stimulation protocols.

Principles and Mechanisms

Basic Principles

Functional electrical stimulation (FES) is a technique that applies controlled electrical currents to stimulate paralyzed or weakened muscles through their intact peripheral , enabling functional movements in individuals with neurological impairments such as or . This method targets motor to produce contractions that mimic natural voluntary actions, thereby restoring or assisting purposeful tasks like grasping or walking. The core mechanism of FES involves delivering short bursts of electrical pulses that depolarize motor neurons in the peripheral , propagating action potentials to the muscle fibers and inducing . These pulses recruit muscle units in a graded manner based on intensity, allowing for controlled force generation that supports functional outcomes without relying on input. The first clinical application of FES was reported in 1961 for correcting in hemiplegic patients by stimulating the peroneal during . Key components of an FES system include electrodes for current delivery, pulse generators to produce the electrical signals, and control systems to synchronize stimulation with or movement phases. Electrodes can be surface-based (non-invasive, adhering to the skin over motor points) or implanted (invasive, for precise targeting), while generators output low-energy pulses adjustable for specific applications. Control mechanisms, often incorporating sensors like goniometers, ensure timed activation to coordinate multiple muscles. FES differs from therapeutic electrical stimulation techniques, such as (TENS), by focusing on motor nerve activation for functional restoration rather than sensory nerve stimulation for relief or general muscle strengthening. While TENS uses higher frequencies to block signals, FES employs parameters optimized for sustained, purposeful contractions. Basic waveforms in FES typically consist of monophasic or biphasic pulses, with biphasic forms preferred for charge balance and to prevent or damage. widths range from 50 to 500 μs to accommodate varying nerve fiber thresholds, and frequencies of 20-50 Hz are used to achieve tetanic contractions for smooth, fused muscle activity without excessive fatigue.

Physiological Effects

Functional electrical stimulation (FES) initiates neural activation by delivering electrical pulses that depolarize nerve fibers, reaching a current typically between 10 and 50 mA for surface to recruit motor units according to the all-or-none principle, where sufficient stimulus intensity triggers a full in the without partial responses. This varies with placement, skin impedance, and fiber proximity, ensuring that only axons above the rheobase are excited, leading to synchronous motor unit firing unlike the asynchronous pattern in voluntary contractions. At the muscle level, FES evokes contractions by reverse-order compared to natural voluntary , preferentially stimulating large-diameter, fast-twitch motor units first due to their lower thresholds based on size, resulting in graded production through increasing stimulus intensity or . This reversal can lead to rapid generation but also higher fatigability, as fast-twitch fibers (type II) are engaged early, contrasting the physiological order that starts with slow-twitch (type I) fibers for . For instance, frequencies around 20-50 Hz promote fused tetanic contractions for sustained , while lower rates elicit twitches. Repeated FES-induced contractions enhance circulation by increasing local blood flow and venous return, improving oxygen delivery and nutrient exchange in the stimulated limbs, which supports metabolic processes like and counters disuse-related hypoperfusion. Metabolically, these contractions elevate energy demands, promoting adaptations such as improved insulin sensitivity and release (e.g., IL-6), though excessive stimulation can accelerate accumulation. Regarding , chronic FES application may attenuate resorption through mechanical loading on the , with some studies showing modest increases in at load-bearing sites, though results vary by duration and intensity. Fatigue during FES arises from multiple mechanisms, including metabolic buildup of and ions that lower and impair cross-bridge , alongside ion imbalances such as extracellular accumulation and intracellular calcium depletion, which reduce muscle excitability and force output over repeated cycles. These factors contribute to a decline in within minutes, exacerbated by the non-physiological pattern that over-relies on fatigable fibers. With prolonged use, FES induces long-term adaptations that counteract , such as evidenced by increased myofiber cross-sectional area (up to 50% in denervated models after 2 years of home-based training) and enhanced enzyme profiles for oxidative metabolism, preventing fiber degeneration in conditions like . This trophic effect stems from restored mechanical and electrical activity, promoting reinnervation and maintaining muscle mass without full voluntary control.

History

Early Developments

The origins of functional electrical stimulation (FES) can be traced to the late , when physician conducted pioneering experiments on the effects of electricity on biological tissues. In the 1780s, Galvani observed that electrical discharges from a applied to frog nerve-muscle preparations triggered contractions, leading him to propose the concept of "animal electricity" as an intrinsic vital force in living organisms. These findings established the fundamental principle that external electrical impulses could activate neural and muscular responses, influencing subsequent research in bioelectricity. By the early , electrical stimulation had evolved into a practical tool for clinical muscle testing and , particularly in assessing nerve integrity and muscle excitability in patients with neuromuscular conditions. Devices like the Electreat, introduced around 1910, delivered controlled currents for diagnostic and therapeutic purposes, such as re-educating paralyzed muscles or evaluating . This era marked the transition from basic experimentation to applied medical use, though applications remained limited to non-functional stimulation without to . A pivotal advancement occurred in 1961, when William T. Liberson and colleagues in the United States developed the first portable FES device specifically for correcting in hemiplegic patients following . The system employed surface electrodes to deliver synchronized electrical pulses to the common peroneal nerve during the swing phase of , triggered by heel switches embedded in the , enabling improved dorsiflexion and step clearance. This innovation represented the initial clinical application of FES as a neuroprosthesis, with early trials showing enhanced walking speed and reduced compensatory deviations in hemiplegic individuals. In the 1970s, British neurophysiologist Geoffrey S. Brindley extended FES into implantable systems, focusing on restoring bladder control for patients. Beginning with conceptual work in 1969, Brindley and colleagues implanted the first sacral anterior root stimulators in humans in 1976, combining electrical activation of sacral ventral roots with posterior to achieve reflex voiding while minimizing detrusor-sphincter . These UK-based trials, involving initial patients at institutions like the National Hospital for and , demonstrated reliable bladder emptying and reduced infection risks, influencing over 500 implants by the 1990s. Key contributors to these foundational efforts included Liberson and his team in the US, where early trials emphasized surface-based correction, and Brindley in the UK. US-UK collaborations, such as those at and Rancho Los Amigos, conducted initial clinical evaluations confirming FES's potential for functional recovery in and hemiplegia. In the , Anton and colleagues advanced FES for restoration in patients, developing multichannel systems to enable standing and walking. Despite these breakthroughs, early FES systems faced significant hurdles, including bulky external components that compromised portability and user comfort, frequent skin irritation or burns from prolonged contact, and short that limited daily usage to under an hour. These limitations restricted widespread until technological refinements addressed them. These pre-1980s developments laid the groundwork for FES's expansion into applications like rehabilitation.

Modern Advancements

In the and , functional electrical stimulation (FES) advanced significantly with the development of multichannel systems designed to restore hand grasp in individuals with . A seminal example is the Freehand system, an implantable eight-channel FES device first implanted in 1986 at , which enabled lateral and palmar prehension by stimulating intrinsic hand muscles and integrating shoulder position sensing for control. This system represented a leap from single-channel stimulation, allowing coordinated activation of multiple muscle groups for functional tasks like grasping objects. Concurrently, hybrid orthoses emerged, combining FES with mechanical braces such as reciprocating gait orthoses to support standing and walking in paraplegic patients by electrically stimulating key lower-limb muscles while providing structural stability. The 2000s marked a shift toward more practical and user-friendly devices through miniaturization enabled by microelectronics and wireless technologies, reducing device size and improving portability for daily use. These innovations facilitated the commercialization of noninvasive systems, exemplified by the WalkAide, a dynamic FES device for foot drop correction that uses tilt sensors and surface electrodes to time dorsiflexion during gait; it received FDA 510(k) clearance in 2005, enabling widespread clinical adoption for stroke and spinal cord injury patients. Wireless controls further enhanced usability by eliminating cumbersome wiring, allowing seamless integration into rehabilitation protocols. Expansions in the focused on sophisticated integrations, including hybrid FES-robot systems for , where robotic exoskeletons provide mechanical guidance while FES activates paralyzed muscles to promote and voluntary control in survivors. Additionally, closed-loop systems incorporating (EMG) feedback became prominent, enabling real-time adjustment of stimulation intensity based on residual muscle activity to optimize movement precision and reduce fatigue. Key milestones included the 2006 European (CE mark) approval of the ActiGait, an implantable peroneal stimulator that wirelessly triggers foot dorsiflexion via an external , offering a discreet alternative to surface electrodes for long-term drop foot management. This era also saw increased availability of home-use devices, broadening access beyond clinical settings. Global adoption accelerated with the establishment of the International Functional Electrical Stimulation Society (IFESS) in 1995, which fosters interdisciplinary collaboration through annual conferences, research dissemination, and standardization efforts to advance FES technologies worldwide. These developments built on earlier precursors, such as 1960s surface stimulators for , but emphasized scalable, evidence-based applications up to the early 2020s.

Technology and Devices

Types of FES Systems

Surface functional electrical stimulation (FES) systems utilize non-invasive, transcutaneous electrodes applied directly to the skin, making them ideal for short-term therapeutic applications and early without requiring surgical intervention. These systems typically employ self-adhesive pads or garment-integrated designs with textile electrodes, such as those in bionic gloves or wearable sleeves, allowing for straightforward application and repositioning while targeting superficial muscles. Examples include commercial neuromuscular electrical stimulation (NMES) pads adapted for FES and flexible systems like the NESS L300, which deliver currents in the range of 2–120 mA for muscle activation. In contrast, implanted FES systems involve the surgical placement of and stimulators within the to achieve higher precision and long-term functionality. Common electrode types include epimysial positioned on the muscle surface and cuff electrodes wrapped around peripheral , as seen in devices like the Freehand System or ActiGait. These designs reduce power needs—often requiring currents around 25 mA—due to direct proximity to target tissues, enabling more selective stimulation of deeper muscles. However, they carry risks such as at the implantation site and the irreversibility of electrode positioning once installed. Hybrid FES systems integrate electrical stimulation with exoskeletons or robotic frameworks to support multi-joint coordination, combining the natural of from FES with mechanical assistance for enhanced stability and reduced fatigue. For instance, lower-limb hybrids pair FES-driven muscle contractions with powered orthoses to compensate for deficits, allowing synchronized control across joints like the , , and ankle. This approach addresses limitations of standalone FES, such as rapid muscle tiring, by distributing loads between neural and robotic actuators. FES systems are further categorized by portability, with battery-powered wearable devices enabling use outside clinical settings, unlike stationary setups confined to environments. A prominent example is the Odstock Dropped Foot Stimulator (ODFS), a compact, self-contained unit with integrated footswitch and electrodes that delivers timed stimulation during walking, facilitating daily activities for users with . The shift toward portable designs accelerated in the , driven by of and , moving FES from cumbersome clinic-based systems to user-friendly wearables. Sensor integration enhances FES responsiveness by enabling closed-loop, gait-triggered operation, where informs timing to align with natural movement phases. Accelerometers detect for phase identification, goniometers measure angles like flexion for precise targeting, and inertial measurement units ()—combining accelerometers, gyroscopes, and magnetometers—provide comprehensive kinematic tracking, as utilized in systems for swing-phase dorsiflexion correction. These sensors, often placed on the or foot, trigger at events such as heel strike, improving coordination and reducing compensatory patterns.

Stimulation Parameters and Control

Functional electrical stimulation (FES) relies on carefully tuned electrical parameters to elicit controlled muscle contractions while minimizing discomfort and . The core parameters include , which refers to the current typically ranging from 0 to 100 for transcutaneous applications, determining the strength of recruitment and muscle force output. Frequency, often set between 1 and 100 Hz but commonly 20-50 Hz for therapeutic effects, controls the rate of muscle activation, with lower frequencies (e.g., 20-25 Hz) preferred to reduce in applications like rehabilitation. , adjustable from 10 to 1000 μs and frequently 50-300 μs in practice, modulates the duration of each electrical to fine-tune in conjunction with . Additionally, incorporates ramping techniques, where stimulation gradually increases and decreases over seconds to enhance user comfort by avoiding abrupt onset discomfort. Control strategies in FES systems vary from open-loop to closed-loop approaches to achieve precise and adaptive . Open-loop control uses pre-programmed stimulation patterns based on fixed timing or user triggers, offering simplicity and reliability in commercial devices for tasks like assistance. In contrast, closed-loop control incorporates from sensors, such as force-sensing resistors for ground reaction forces or inertial measurement units for position and phase detection, enabling dynamic adjustments to maintain desired movement trajectories. These strategies ensure synchronization with natural , with closed-loop systems showing greater prevalence in for improved despite higher . Modulation techniques further optimize FES delivery by enhancing selectivity and endurance. Interleaved stimulation alternates pulses across multiple channels or electrodes, promoting selective and smoother generation with reduced ripple and fatigue compared to synchronous methods. Adaptive algorithms, often integrated into closed-loop frameworks, automatically adjust parameters like or based on detected , using techniques such as iterative learning control or finite state machines to sustain performance over extended sessions. These parameters influence the physiological order of motor units, prioritizing larger fibers for graded production. Power sources for FES devices emphasize portability and longevity, predominantly utilizing rechargeable lithium-ion batteries to support prolonged use. Common examples include high-capacity cells like the NCR18650A, providing nominal voltages around 3.7 V and capacities sufficient for hours of stimulation. is quantified by metrics such as charge per pulse, calculated as the product of and (in coulombs), which directly correlates with and life, typically optimized to below 1 μC per pulse for low-power operation in wearable systems. Modern FES systems incorporate software interfaces for user-driven , enhancing and . Dedicated applications, often with graphical user interfaces (GUIs), allow patients or clinicians to adjust parameters, session , and program patterns via smartphones or tablets connected to the device. These apps facilitate on-the-fly modifications, such as for clinical trials or real-time feedback integration, promoting adherence through intuitive controls.

Clinical Applications

Spinal Cord Injury

Functional electrical stimulation (FES) is applied in (SCI) rehabilitation primarily to restore lower limb and trunk function by activating paralyzed muscles through electrical impulses delivered via surface or implanted electrodes. This technique targets key muscle groups such as the for knee extension during stance, hamstrings for knee flexion in swing, and gluteals for stabilization, enabling assisted movements that mimic natural patterns. By synchronizing stimulation with the patient's residual motor capabilities, FES facilitates therapeutic exercises that promote and functional recovery, particularly in incomplete injuries. Primary applications include FES-assisted standing, , and walking, which address limitations while providing secondary health benefits. For standing, systems stimulate lower limb extensors to support upright against , often using a or frame for balance. involves rhythmic multichannel stimulation of leg muscles to drive pedal rotation, enhancing endurance without full . Walking protocols employ FES to generate reciprocal stepping, typically over short distances with assistive devices. Seminal systems like the Parastep, FDA-approved in 1994, utilize a portable, non-invasive setup with up to 12 surface electrodes and a command controller to enable upright and limited ambulation, such as 6-9 meters per session. Additionally, functional electrical (FET) integrates FES with task-specific training to promote neurorecovery, focusing on repetitive, patterned of lower limb muscles to strengthen neural pathways. Clinical outcomes demonstrate improvements in cardiovascular health through increased and oxygen utilization during FES sessions, reducing risks associated with sedentary lifestyles in patients. benefits from activities like standing, with studies showing partial reversal of in the lower extremities after consistent use. In incomplete , partial ambulation is achievable, with some individuals gaining enhanced walking speed and distance, though full independence remains limited. Protocols typically involve multichannel stimulation (4-16 channels) synchronized with body weight support systems or treadmills to ensure safe progression, starting with low-intensity sessions and advancing based on tolerance. Patient selection favors those with incomplete SCI classified as ASIA Impairment Scale (AIS) C or D, where residual voluntary control allows better integration of FES with natural movement. Contraindications include a history of significant in individuals with SCI at or above T6, as well as conditions like pacemakers, severe , or skin integrity issues that could lead to injury.

Stroke and Upper Limb Recovery

Functional electrical stimulation (FES) is widely applied in the of hemiparetic upper limbs following , targeting muscles such as wrist extensors and finger flexors to facilitate hand opening and closing for task-specific activities like grasping objects. Commercial systems like the Bioness H200, a wearable neuroprosthesis, deliver coordinated stimulation to multiple muscle groups, enabling functional hand movements during daily activities and therapy sessions. In a randomized controlled trial involving subacute patients, the use of the H200 alongside standard led to significant improvements in upper extremity function compared to rehabilitation alone, with gains in motor and dexterity persisting over 12 weeks. Therapeutic protocols incorporating FES emphasize repetitive, task-oriented practice to harness , often through bilateral arm training where the unaffected limb guides movements while FES activates the paretic side. This approach promotes interhemispheric communication and cortical reorganization, facilitating carryover of motor gains to unilateral tasks. Bilateral FES training, typically involving 15 sessions of synchronized stimulation and exercises, has demonstrated enhanced active and functional performance in chronic survivors. Clinical trials provide evidence of FES efficacy, with meta-analyses showing moderate to large improvements in Fugl-Meyer Assessment scores for motor function and (ADLs) in patients. For instance, standardized mean differences indicated a 0.69 for activity versus no . Optimal outcomes are observed when FES is initiated within 2 months post-, yielding significant ADL gains (SMD 1.24), whereas benefits diminish in chronic phases beyond 1 year. FES integration with further amplifies these effects by combining forced use of the affected limb with electrical facilitation, enhancing motor relearning in subacute stages. Challenges in FES application for upper limb recovery include managing spasticity, which can interfere with muscle activation, and precise electrode placement on the affected arm to avoid discomfort or ineffective stimulation. Surface electrodes, typically self-adhesive and positioned over target muscle bellies like the extensor digitorum, require adjustment based on individual and response to optimize contraction without exacerbating spastic patterns. Protocols often limit inclusion to mild spasticity (Modified Ashworth ≤2) to ensure tolerability.

Foot Drop and Other Conditions

Functional electrical stimulation (FES) is widely applied to manage , a condition characterized by impaired dorsiflexion of the foot during the swing phase of , often resulting from or other neurological impairments. By delivering timed electrical pulses to the common peroneal nerve, FES activates the to facilitate ankle dorsiflexion, thereby improving foot clearance and reducing the risk of tripping. Clinical studies have demonstrated that peroneal nerve FES significantly enhances walking speed, with improvements ranging from 23% to 47% in patients with chronic , compared to without stimulation. Additionally, such interventions have been associated with reduced fall incidence, as evidenced by longitudinal data showing decreased fall risk in users over periods of up to 11 months. Devices like the WalkAide exemplify lightweight, unilateral FES systems designed for ambulatory use, incorporating tilt sensors to trigger stimulation synchronized with the gait cycle. These portable neuroprostheses, weighing under 100 grams, enable daily community walking by providing orthotic support without the bulk of traditional ankle-foot orthoses. In clinical evaluations, WalkAide use has led to sustained gains in velocity (up to 38%) and stride length, alongside improvements in patient satisfaction and reduced in non-progressive cases. In (MS), FES targets gait impairments and associated symptoms like and dysfunction to promote more efficient, -resistant walking. Peroneal FES during gait training has shown positive orthotic effects, increasing walking speed by approximately 11-19% in people with MS, as measured during device use in systematic reviews of randomized trials. For management, percutaneous tibial nerve stimulation (a form of FES) has shown improvements in urinary continence and reduced incontinence episodes in MS patients with neurogenic lower urinary tract dysfunction. These applications contribute to overall gains, including better endurance for prolonged walking without excessive . Pediatric applications of FES are particularly relevant for (), especially , where it aids in correcting deviations such as flexed-knee patterns during stance. By stimulating muscles, FES promotes extension, leading to improved stance stability and reduced crouch in children. Randomized crossover trials have found that FES-assisted increases muscle strength and volume in unilateral , with significant enhancements in walking speed and after 6-12 weeks of intervention. In diplegic cases, individualized FES parameters during overground walking have demonstrated feasibility and improvements in step length and symmetry, supporting its role in early for children. For other conditions like , FES addresses (FOG) by providing rhythmic sensory cues through peroneal or plantar stimulation, which helps initiate and sustain steps. Clinical evidence indicates that FES reduces FOG episodes and improves velocity, with users experiencing increased stride length and fewer trips or falls during daily activities. Overall outcomes across these applications include enhanced walking velocity (typically 0.1-0.2 m/s gains), lower fall risk (reductions up to 50% in some cohorts), and better through lightweight, user-friendly devices that facilitate independent ambulation.

Evidence, Guidelines, and Safety

Clinical Evidence and Efficacy

Functional electrical stimulation (FES) has been evaluated in numerous randomized controlled trials (RCTs) and meta-analyses, demonstrating moderate efficacy in improving motor function across various neurological conditions, particularly when integrated with conventional therapies. A 2023 meta-analysis of 8 RCTs involving 358 stroke patients found that FES combined with occupational therapy (OT) significantly enhanced upper limb motor recovery, as measured by the Fugl-Meyer Assessment (mean difference: 9.04 points; 95% CI: 5.34-12.73), compared to OT alone. Similarly, in applications for spinal cord injury and stroke, FES has shown consistent benefits in restoring functional movements, such as grasp and gait. Key efficacy metrics include improvements in functional outcomes like the 6-minute walk test (6MWT), where meta-analyses report average increases of 20-40 meters in and patients using FES for . assessments, such as the , indicate gains in physical functioning domains, with one RCT in patients showing a 10-15 point improvement in the physical component summary score after 12 weeks of FES use. evidence from fMRI studies reveals cortical reorganization, including increased activation in the ipsilesional following FES-assisted training in chronic survivors. Despite these findings, clinical evidence is tempered by limitations such as high heterogeneity in trial designs (I² > 70% in many meta-analyses), small sample sizes (often n < 50 per arm), and predominantly short-term follow-ups (≤6 months), which restrict generalizability and long-term outcome assessments. Subgroup analyses from systematic reviews highlight superior outcomes in the subacute phase (within 3-6 months post-injury) and with multimodal approaches, such as FES combined with robotic therapy, yielding up to 25% greater motor gains than FES monotherapy. Regarding cost-effectiveness, UK-based trials demonstrate that home-based FES reduces overall healthcare utilization, with an incremental cost-effectiveness ratio of £15,406 per gained over 5 years, primarily through decreased falls and therapy visits. US studies echo this, reporting annual savings of $2,000-4,000 per patient via sustained home use in management. For specifically, RCTs indicate 15-25% improvements in gait speed (e.g., from 0.6 to 0.75 m/s), supporting its role in enhancing community ambulation.

Regulatory Guidelines

In the , the National Institute for Health and Care Excellence () issued guidance in 2009 recommending functional electrical stimulation (FES) for managing of central neurological origin, including conditions such as (MS) and , particularly when conventional ankle-foot orthoses have failed or are unsuitable (current as of 2025). This interventional procedure guidance (IPG278) supports the use of FES to improve by stimulating the common peroneal nerve, emphasizing its and efficacy based on available evidence at the time. In the United States, the (FDA) classifies most non-invasive FES devices as Class II medical devices, subject to 510(k) premarket notification for clearance. For example, the NESS L300 system, cleared in 2008, is indicated for facilitating ankle dorsiflexion in adults with due to injury or disease, such as , , or incomplete (SCI), and is approved for home and community use. Similarly, subsequent clearances for devices like the L300 Go (cleared 2018) extend indications to include knee flexion or extension for hemiplegia and , ensuring these systems meet general and special controls for electrical safety and performance. For implantable FES systems, such as those used in advanced SCI rehabilitation, compliance with the European Union's Medical Device Regulation (MDR, Regulation (EU) 2017/745) is required, typically classifying them as Class IIb or III devices due to their invasive nature and potential risks. These regulations mandate rigorous clinical evaluation, post-market surveillance, and unique device identification to ensure safety and performance across member states. Reimbursement policies in the US further support FES access; under Medicare's National Coverage Determination (NCD 160.12), coverage is provided for FES in SCI patients who have intact lower motor neurons, demonstrate potential for functional improvement, and complete a qualifying training program of at least 32 one-on-one physical therapy sessions. Specific devices like the Parastep system for ambulation are covered as durable medical equipment when criteria are met, though coverage for foot drop devices like the NESS L300 requires demonstration of medical necessity. Recent updates to guidelines, such as the 2022 evidence-based clinical practice guidelines from the Association of Chartered Physiotherapists in (ACPIN), provide recommendations for FES to improve mobility in adults with lower limb impairment due to upper motor neuron lesions, building on NICE's foundational recommendations.

Safety Considerations

Functional electrical stimulation (FES) carries several common risks, primarily related to surface-level and muscular effects. Skin irritation and redness are frequent, often resulting from placement and typically resolving within 24 hours, while burns can occur due to poor contact or excessive . Muscle fatigue is another prevalent issue, which may lead to overuse injuries if exceeds the muscle's capacity during prolonged sessions. Contraindications for FES include the presence of pacemakers or implantable cardioverter defibrillators, particularly for upper body or torso stimulation due to risks, though lower limb use is generally safe with monitoring. , , and near the stimulation site are also contraindicated, as stimulation may trigger seizures, affect fetal development, or promote tumor growth through increased local blood flow. Additional exclusions encompass open wounds, metal implants at the site, and uncontrolled . For implanted FES systems, such as intramuscular electrodes, risks include rates of approximately 1-5% and lead migration, which can compromise device function and necessitate surgical revision. protocols involve regular clinical assessments, for lead positioning, and prompt for signs of like or swelling to mitigate these complications. Safe use guidelines emphasize limiting current to under 50 mA, with amplitudes often kept below 20 mA to prevent tissue damage, alongside session durations of 20-60 minutes to avoid . User training is essential, focusing on proper application, parameter adjustments for comfort, and immediate reporting of discomfort. Biphasic pulses with short durations (1-300 µs) and duty cycles under 50% effective time further enhance safety. Long-term FES application, such as in cycling or standing programs, can aid in preventing by increasing density through mechanical loading, though it may introduce joint stress in scenarios, requiring careful progression to avoid overuse.

Recent Advances

Integration with Emerging Technologies

Recent advancements in functional electrical stimulation (FES) have increasingly integrated it with to enhance hand function restoration in individuals with (). Hybrid systems combining flexible exosuits with FES deliver targeted muscle stimulation while providing mechanical support, improving grasp precision and endurance during . A 2022 narrative review highlighted that such integrations, tested in clinical pilots, enable synergistic effects where assists passive movement and FES activates muscles, leading to significant gains in hand motor scores for patients. Battery-free implantable platforms represent a breakthrough in chronic FES delivery for SCI, eliminating the need for surgical battery replacements and enabling long-term wireless operation. A 2023 study in Nature Communications introduced a fully implanted, ultrasound-powered device capable of delivering high-power (over 300 mW) stimulation to both spinal and peripheral muscles via an eight-channel array. In rodent models of chronic SCI, this platform sustained functional recovery, including improved locomotion, over six weeks without complications, demonstrating biocompatibility and precise control for human translation. Artificial intelligence and have enabled adaptive FES control by predicting user movement intent from multimodal data, enhancing responsiveness in neurorehabilitation. These systems use algorithms to process EEG signals for brain-computer interfaces or IMU data for kinematic feedback, dynamically adjusting stimulation parameters to align with intended actions. Brain-computer interface-driven FES integrates EEG-based intent detection to trigger stimulation, promoting and voluntary recovery. A 2024 adaptive framework for human-robot-FES collaboration utilized IMU data to refine assistance, reducing compensatory patterns in participants. Combining FES with other techniques, such as (DBS) or (tDCS), amplifies recovery outcomes in by targeting multiple neural levels. A 2024 review on DBS for SCI motor restoration detailed how pairing it with FES promotes circuit remodeling, with preclinical evidence showing enhanced lower limb function through synchronized spinal and subcortical activation. For tDCS-FES hybrids, a 2025 focused on noted that anodal tDCS modulates cortical excitability to boost FES-induced plasticity. Broader 2025 neuromodulation overviews for SCI emphasize these combos' role in reducing and fostering enduring gains via complementary mechanisms. Integration of advanced wearable inertial measurement units () with FES systems facilitates real-time correction for conditions like (), where impairs mobility. These sensors detect subtle deviations in stride length and cadence, triggering precise FES pulses to dorsiflexor muscles for smoother heel-toe progression. Such setups, evolving from multichannel FES, prioritize unobtrusive monitoring for home-based .

Ongoing Research and Future Directions

Current research in functional electrical stimulation (FES) highlights significant gaps in understanding long-term , particularly in patients with complete (), where sustained functional improvements remain elusive despite short-term gains in motor . Studies indicate that while FES promotes initial synaptic strengthening and axonal below the injury site, the durability of these plastic changes over years is poorly characterized, necessitating longitudinal trials to assess persistent rewiring in denervated circuits. Emerging efforts also explore personalized FES protocols, though clinical translation remains limited by the need for integrated data. Future technological developments focus on non-invasive brain-computer interfaces (BCIs) to trigger FES more intuitively, enabling direct translation of intent signals from (EEG) to muscle activation for seamless control in and patients. These hybrid systems, which decode to synchronize FES pulses, show promise in enhancing voluntary movement precision without surgical intervention. Complementing this, regenerative applications combine FES with stem cell therapies to amplify neural repair, potentially restoring endogenous repair mechanisms. Recent clinical trials from 2024 to 2025 are investigating FES-like for (ALS), including the MyoRegulator device, a non-invasive electrical stimulation system that targets hyperexcitability to slow disease progression, with early feasibility studies reporting safety and preliminary efficacy in maintaining function. For post-COVID neuropathy, trials explore related electrical nerve stimulation approaches, such as transcutaneous devices to alleviate persistent pain and sensory deficits, demonstrating reduced symptoms in small cohorts but requiring larger randomized designs to confirm benefits for functional recovery. Key challenges include limited accessibility of FES in low-resource settings, where high device costs, lack of trained personnel, and inadequate hinder widespread , particularly in developing countries with high SCI prevalence. Ethical concerns arise with implants, emphasizing the need for enhanced protections around , long-term risks, and equitable access to minimize disparities in vulnerable populations. Looking ahead, FES holds potential for full neuroprosthetic limbs that integrate sensory feedback and natural movement, with bidirectional interfaces restoring touch sensation alongside actuated motion to achieve near-physiological control in amputees and individuals. Integrations with AI-driven controls may further refine adaptive stimulation patterns, optimizing outcomes based on real-time .

References

  1. [1]
    Functional electrical stimulation therapy for restoration of motor ...
    May 24, 2020 · Functional electrical stimulation is a technique to produce functional movements after paralysis. Electrical discharges are applied to a person's muscles ...
  2. [2]
    Functional Electrical Stimulation - an overview | ScienceDirect Topics
    Functional electrical stimulation (FES) is a technique of eliciting controlled neural activation through the application of low levels of electrical current.
  3. [3]
    A systematic review on functional electrical stimulation based ... - NIH
    Dec 8, 2023 · The main objective of this paper is to provide a comprehensive systematic review of the start-of-the-art functional electrical stimulation (FES) ...
  4. [4]
    Functional electrical stimulation therapy for restoration of motor ...
    May 24, 2020 · Functional electrical stimulation is a technique to produce functional movements after paralysis. Electrical discharges are applied to a person's muscles ...
  5. [5]
    Therapeutic Effects of Functional Electrical Stimulation on Physical ...
    Mar 22, 2022 · Principles of FES. FES is the clinical application of electric current to a decentralized muscle. Neuromuscular electrical stimulation involves ...
  6. [6]
    stimulation of the peroneal nerve synchronized with the swing phase ...
    Functional electrotherapy: stimulation of the peroneal nerve synchronized with the swing phase of the gait of hemiplegic patients ... Arch Phys Med Rehabil. 1961 ...
  7. [7]
    mechanisms underlying electrical stimulation of muscles and nerves ...
    Nov 4, 2020 · Typical FES pulse amplitudes rarely exceed 100 mA, while the exact levels depend on muscle properties, including the size of the muscle as well ...
  8. [8]
    Functional electrical stimulation for incomplete spinal cord injury - NIH
    FES reverses the order in which muscle fibers are recruited from that of a volitional muscle contraction. Fast-twitch, fatigable muscle fibers are recruited ...
  9. [9]
    Functional electrical stimulation-induced muscular fatigue: Effect of ...
    FES-induced activation reportedly initiates fiber recruitment in reverse order to the pattern of recruitment observed during voluntary activation, leading to ...
  10. [10]
    Health and Fitness Benefits of Functional Electrical Stimulation ...
    May 20, 2009 · Evidence from FES-evoked exercise studies demonstrated (a) positive changes within skeletal muscle, (b) enhanced cardiovascular and peripheral ...
  11. [11]
    Neural and muscular mechanisms of electrically induced fatigue in ...
    Jan 21, 2014 · It is well acknowledged that NMES-induced fatigue does not involve only muscular mechanisms, but also changes taking place at the neural level.
  12. [12]
    Factors in fatigue during intermittent electrical stimulation of human ...
    In over half of the subjects, however, marked fluctuations in the force level occurred during the fatigue test, suggesting the presence of electrical fatigue.
  13. [13]
    Biology of Muscle Atrophy and of its Recovery by FES in Aging and ...
    Aug 25, 2015 · The conclusion is that h-b FES training (5 times a week at 3h a day) reverts atrophy and maintains trophism of the muscle fibers in long-term ...
  14. [14]
    Home-Based Functional Electrical Stimulation for Long-Term ...
    Even without axonal neurotropic substances FES was able to demonstrate fiber hypertrophy, enzyme adaptation and intracellular structural benefits in denervated ...
  15. [15]
    The Long Journey from Animal Electricity to the Discovery of Ion ...
    Early in the 1780s, Galvani showed that stimulation of the nerve with the Leyden jar, which would deliver an electric shock to the preparation, triggered ...Missing: galvanism | Show results with:galvanism
  16. [16]
    Frogs and Animal Electricity | Whipple Museum
    In the 1780s, the Bolognese physician Luigi Galvani (1737-1798) conducted a vast range of experiments on electricity's effect on "prepared" frog specimens ...Missing: functional | Show results with:functional
  17. [17]
    History of Electrical Neuromodulation for Chronic Pain | Pain Medicine
    Apr 10, 2006 · The first electrical stimulator designed specifically for treatment was the Electreat, which appeared at the beginning of the 20th century.
  18. [18]
    History of electromyography and nerve conduction studies - PubMed
    In 1771, Galvani showed that electrical stimulation of animal muscle tissue produced contraction and, thereby, the concept of animal electricity was born.
  19. [19]
    Advances in neuroprosthetic management of foot drop: a review
    Mar 25, 2020 · The first neuroprosthesis based on FES was developed in 1961 by Liberson et al. [12]. It was controlled by a foot switch that activated a ...
  20. [20]
    History of the Sacral Anterior Root Stimulator, 1969-1982 - PubMed
    History of the Sacral Anterior Root Stimulator, 1969-1982. Neurourol Urodyn. 1993;12(5):481-3. doi: 10.1002/nau.1930120506. Author. G S Brindley. Affiliation.
  21. [21]
    The first 500 patients with sacral anterior root stimulator implants
    Abstract. The first 500 patients to have sacral anterior root stimulators implanted for bladder control are described. Of 479 survivors, 424 were using their ...Missing: Geoffrey paper
  22. [22]
    William Herbert Sweet - Harvard Gazette
    Mar 2, 2006 · In the field of intractable chronic pain, he introduced the use of electrical stimulation to suppress sensory pain mechanisms. In the field ...
  23. [23]
    History of FES - Odstock Medical
    The term Functional Electrical Stimulation was introduced by Moe and Post. 1970s. Professors Nightingale and Glanville start FES treatment in Southampton ...Missing: 1960s | Show results with:1960s
  24. [24]
    Functional electrical stimulation after spinal cord injury - Nature
    Sep 11, 2007 · During the 1970s ... Functional Electrical Stimulation for Ambulation by Paraplegics: 12 Years of Clinical Observations and System Studies.Missing: UK | Show results with:UK
  25. [25]
    [PDF] SEP 21 2005 Innovative Neurotronics, Inc. WalkAide System
    Sep 21, 2005 · The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and ...Missing: clearance | Show results with:clearance
  26. [26]
    Combining Upper Limb Robotic Rehabilitation with Other ...
    A randomized controlled trial in patients with chronic stroke [55] found that a robotic device driven by EMG that provided FES to the wrist was more effective ...
  27. [27]
    (PDF) Real-Time Closed-Loop Functional Electrical Stimulation ...
    Aug 9, 2025 · Through delivery of electrical pulses to muscles of motor-impaired subjects, FES is able to artificially induce their muscle contractions.
  28. [28]
    Latest implantable and external neurostimulation technology for ...
    Sep 24, 2013 · Both StimuStep and ActiGait have been implanted in a number of European countries in recent years. ActiGait was launched in the UK in late 2011 ...Missing: EU approval<|control11|><|separator|>
  29. [29]
    History - IFESS
    Foundation in 1995. The idea to found an International Society for Functional Electrical Stimulation was born in 1993 after the Ljubljana IFESS meeting in ...
  30. [30]
    Review of hybrid exoskeletons to restore gait following spinal cord ...
    FES uses the muscles as natural actuators to generate gait, providing not only functional but also psychological benefits to the users. However, disadvantages ...
  31. [31]
  32. [32]
    A review of portable FES-Based neural orthoses for the correction of ...
    Aug 6, 2025 · This paper reviews the technological developments in neural orthoses for the correction of upper motor neurone drop foot since 1961, ...
  33. [33]
    Sensing and Control Strategies Used in FES Systems Aimed at ...
    Aug 17, 2024 · The control strategy most reported is closed-loop; however, most of the current commercial FES systems employ open-loop strategies due to their ...
  34. [34]
    The influence of functional electrical stimulation on hand motor ...
    Aug 21, 2014 · Stimulation parameters for successful FES are in the range of (I) frequency: 20 – 50 Hz, (II) pulse width: 30 – 500 μs, (III) amplitude ≤ 100 ...
  35. [35]
    Interleaved multichannel epimysial stimulation for eliciting smooth ...
    Specifically, we employ an interleaved stimulation protocol to achieve force responses with less fatigue and less ripple than those produced by standard ...
  36. [36]
    STIMGRASP: A Home-Based Functional Electrical Stimulator ... - MDPI
    However, a downside of constant-current stimulation is the possibility of causing skin burns due to a current density increase above 0.5 mA/cm 2 in residual ...2. Materials And Methods · 2.2. Circuit Design · 2.2. 2. Biphasic Pulse...Missing: initial bulky irritation
  37. [37]
    Functional Electrical Stimulation - The Ultimate Guide to FES
    Charge & Torque ... Total charge, the product of combined amplitude and pulse width, determines the force produced from the resultant muscle contraction.
  38. [38]
    Encoder-Controlled Functional Electrical Stimulator for Bilateral ...
    Sep 24, 2022 · The apps present a graphical user interface (GUI) for the user and, via the firmware, receive information on the difference in angle of the ...
  39. [39]
    [PDF] Design of a Smartphone Application with Integrated Functional ...
    Mar 14, 2016 · The design and evaluation of a smartphone application using a User Centred Design approach to provide automatic blind randomization control and ...
  40. [40]
    Functional Electrical Stimulation in Paraplegia - IntechOpen
    Jul 2, 2014 · 3.3. Hybrid FES-Orthosis ambulation systems. A variety of mechanical orthoses have been designed and tested for lower-limb function after SCI.
  41. [41]
    Functional Electrical Stimulation and Spinal Cord Injury - PMC
    A coordinated stimulation pattern is developed so that the muscles are activated in a sequence that produces a functional grasp pattern as the user typically ...
  42. [42]
    Functional electrical stimulation improves activity after stroke - PubMed
    Conclusions: FES appears to moderately improve activity compared with both no intervention and training alone. These findings suggest that FES should be used in ...
  43. [43]
    Functional electrical stimulation enhancement of upper extremity ...
    Neurorehabil Neural Repair. 2007 May-Jun;21(3):207-15. doi: 10.1177/1545968306297871. Epub 2007 Mar 16. Authors. Gad Alon , Alan F Levitt ...
  44. [44]
    Bilateral upper limb training with functional electric stimulation in ...
    Conclusions: Bilateral upper limb training with FES could be an effective method for upper limb rehabilitation of stroke patients after 15 training sessions.
  45. [45]
    Effectiveness of upper limb functional electrical stimulation after ...
    Feb 28, 2017 · This review found a statistically significant benefit from FES applied within 2 months of stroke on the primary outcome of ADL.Missing: recovery | Show results with:recovery
  46. [46]
    The Use of Functional Electrical Stimulation on the Upper Limb and ...
    May 9, 2017 · The application of FES to the UL and interscapular muscles of stroke patients with motor impairment of the UL has improved reaching movements.
  47. [47]
    A survey on foot drop and functional electrical stimulation
    Mar 13, 2019 · FES devices provide relief from foot drop using electrical stimulus to cause muscle contraction during the gait cycle. Electrodes are placed on ...Missing: portable stationary
  48. [48]
    Effects of functional electrical stimulation on gait in people ... - PubMed
    The evidence presented in this review suggests that FES has a positive orthotic effect on walking in PwMS. Yet, more robust trials are needed to substantiate ...Missing: bladder | Show results with:bladder
  49. [49]
    Functional electrical stimulation to aid walking in patients with ...
    Oct 19, 2021 · FES has also been shown to improve urinary incontinence in patients with progressive neurological conditions, such as multiple sclerosis.
  50. [50]
    A randomized crossover study of functional electrical stimulation ...
    Jan 13, 2022 · Neuromuscular electrical stimulation-assisted gait increases muscle strength and volume in children with unilateral spastic cerebral palsy.
  51. [51]
    Evaluation of Individualized Functional Electrical Stimulation ... - MDPI
    Jun 29, 2021 · We aimed to demonstrate the feasibility of using a FES system with increased stimulation options during walking in children with cerebral palsy (CP).
  52. [52]
    Functional electrical stimulation may reduce bradykinesia in ... - NIH
    The study showed that FES use was associated with reduced episodes of freezing, increased gait speed, increase stride length and reduced incidence of trips and ...
  53. [53]
    Meta-Analysis of Functional Electrical Stimulation Combined with ...
    Dec 28, 2023 · Some research has suggested that tDCS holds promise for aiding in the recovery of motor function in acute, subacute, or chronic stroke ...
  54. [54]
    (PDF) Functional Electrical Stimulation for Improving Gait in Persons ...
    Aug 10, 2025 · ... 6-minute walk test (6MWT). Pooled analysis was conducted for treatment effect of FES on the 6MWT distance using a fixed effects model.
  55. [55]
    Effects of Functional Electrical Stimulation on Gait Function and ...
    Jan 1, 2015 · Use of functional electrical stimulation demonstrates improvement in gait speed, perceived walking ability, and physical domains of quality of ...
  56. [56]
    Brain-actuated functional electrical stimulation elicits lasting arm ...
    Jun 20, 2018 · Here we show that BCI coupled to functional electrical stimulation (FES) elicits significant, clinically relevant, and lasting motor recovery in chronic stroke ...
  57. [57]
    The long-term cost-effectiveness of the use of Functional Electrical ...
    The average treatment cost was £3,095 per patient resulting in a mean cost per Quality Adjusted Life Years of £15,406. Conclusion: FES is a practical, long- ...Missing: home US trials
  58. [58]
  59. [59]
    A Systematic Review and Meta-Analysis of the Effect on Gait Speed
    Conclusions: FES used for foot drop has a positive initial and ongoing effect on gait speed in short walking tests. Further fully powered randomized controlled ...
  60. [60]
    Functional electrical stimulation for drop foot of central neurological ...
    Jan 28, 2009 · This involves stimulating the peripheral nerves that supply the paralysed muscle using electrodes to restore muscular function.Missing: stroke 2020
  61. [61]
    [PDF] 510(k) Summary: NESS L300 - accessdata.fda.gov
    Jan 29, 2008 · Device Name: NESS L300 Indications for Use: The NESS L300 is intended to provide ankle dorsiflexion in individuals with drop foot following an ...Missing: FES | Show results with:FES
  62. [62]
    [PDF] March 9, 2018 Bioness, Inc. Mary Dadone, Ph.D. 25103 Rye ...
    Mar 9, 2018 · The L300 Go System electrically stimulates muscles in the affected leg to provide ankle dorsiflexion of the foot and/or knee flexion or ...
  63. [63]
  64. [64]
    FES - Coverage and HCPCS Coding - Revised - JA DME - Noridian
    Medicare will consider coverage of FES for SCI patients who have completed a training program consisting of at least 32 physical therapy sessions with the ...
  65. [65]
    Functional Electrical Stimulation Therapy for Retraining Reaching ...
    Jul 9, 2020 · There are specific principles of the FES therapy as applied in our studies: (i) stimulation is applied using surface stimulation electrodes, ( ...
  66. [66]
    What to Know About Electrical Stimulation Therapy - Verywell Health
    Jul 2, 2025 · Electrical stimulation is a treatment that sends small electrical signals to nerves and muscles to help reduce pain, improve movement, and support healing.
  67. [67]
    [PDF] Safety and best practice in neuromuscular electrical stimulation for ...
    The aim of this particular statement is to out- line best practice and safety considerations for clinician- led neuromuscular electrical stimulation. (NMES) for ...
  68. [68]
    The safety of electrical stimulation in patients with pacemakers and ...
    Dec 5, 2017 · Conclusion. This systematic review indicates that FES for drop foot could be considered safe in patients with pacemakers and ICDs.Missing: considerations | Show results with:considerations
  69. [69]
    Understanding the Contraindications of Functional Electrical ...
    Skin Conditions: Open wounds, infections, or skin irritations at the electrode site can worsen with the use of FES. It's important to ensure the skin is ...
  70. [70]
    Electrode fracture rates and occurrences of infection and granuloma ...
    ... infection and granuloma associated with percutaneous intramuscular electrodes implanted in upper-limb muscles ... functional electrical stimulation applications.
  71. [71]
    (PDF) Electrode fracture rates and occurrences of infection and ...
    ... rates and occurrences of infection and. granuloma associated with percutaneous intramuscular electrodes. in upper-limb functional electrical stimulation ...
  72. [72]
    Safety of long-term electrical peripheral nerve stimulation
    Jan 18, 2019 · Currently, chronic stimulation at frequencies below 30 Hz and percentages of effective stimulation time below 50% is considered safe.<|control11|><|separator|>
  73. [73]
    The Effects of Aging and Electrical Stimulation Exercise on Bone ...
    Feb 7, 2013 · It appears that FES-LCE may help slow the process of bone loss in early SCI as well as increase BMD long after SCI. These results are concordant ...Missing: circulation | Show results with:circulation
  74. [74]
    Soft robotics and functional electrical stimulation advances for ...
    The present narrative review aims to identify the effects of FES, SR and their combination in the recovery of hand function in people with SCI. Therefore, this ...Missing: exosuits | Show results with:exosuits
  75. [75]
    Fully implanted battery-free high power platform for chronic spinal ...
    Nov 30, 2023 · The device has the capability for both spinal and muscular functional electrical stimulation (FES) using an eight-channel electrode array ...
  76. [76]
    A feasibility study on AI-controlled closed-loop electrical stimulation ...
    Jun 22, 2023 · Here, we study the feasibility of more computationally efficient machine learning methods to control ES implants.Missing: adaptive | Show results with:adaptive
  77. [77]
    Advances in brain-computer interface controlled functional electrical ...
    Jun 15, 2025 · This paper reviews the application of BCI-FES in the recovery of upper limb function after stroke and explores its underlying mechanisms.
  78. [78]
    [PDF] Adaptive Control for Triadic Human-Robot-FES Collaboration in Gait ...
    Jan 31, 2024 · Sharma,. “Shared Control of a Powered Exoskeleton and Functional Electrical. Stimulation Using Iterative Learning,” Frontiers in Robotics and AI ...<|separator|>
  79. [79]
    DBS in the restoration of motor functional recovery following spinal ...
    Dec 3, 2024 · This review aims to provide an overview of the neural circuitry remodeling mechanisms of deep brain stimulation (DBS) after spinal cord injury, ...
  80. [80]
    Combined Transcranial Direct Current Stimulation and Functional ...
    Recent meta-analyses have shown that FES is superior to other electrical stimulation methods for improving UL function and can be combined with robotic-assisted ...
  81. [81]
    Neuromodulation techniques for the treatment of spinal cord injury
    Jun 19, 2025 · By electrically stimulating nerves, FES can enhance muscle contraction, increase muscle strength, and optimize motor performance. FES applies ...
  82. [82]
    Innovative multidimensional gait evaluation using IMU in multiple ...
    Inertial measurement units (IMUs) are small, lightweight wearable sensors that can be used to assess gait in MS both in routine clinical practice and at home ...Missing: advanced | Show results with:advanced
  83. [83]
    Electrical stimulation for the treatment of spinal cord injuries - Frontiers
    One potential treatment is electrical stimulation, which has shown promising functional improvements when delivered epidurally over the spinal cord or to ...
  84. [84]
    Electrical stimulation for the treatment of spinal cord injuries
    Feb 3, 2023 · Epidural electrical stimulation, peripheral nerve stimulation, and functional electrical stimulation have shown promising improvements for individuals with SCI.
  85. [85]
    Personalized strategies of neurostimulation: from static biomarkers ...
    Mar 7, 2024 · The neurostimulation field has seen in recent years a widespread of methods aimed at the personalization of its parameters, based on biomarkers of the ...
  86. [86]
    Non-invasive, Brain-controlled Functional Electrical Stimulation for ...
    May 1, 2019 · We describe a neurorehabilitation setup combining several approaches that were shown to have a positive effect in patients with SCI.
  87. [87]
    Brain-Computer Interface Training With Functional Electrical ...
    Sep 26, 2021 · The current study provides new evidence that suggest that non-invasive EEG-based BCI with FES intervention can facilitate changes in ...
  88. [88]
    Electrical modulation of transplanted stem cells improves functional ...
    Mar 15, 2022 · Using this system, electrical modulation of human stem cell transplants improve functional stroke recovery in rodents. Increased endogenous stem ...
  89. [89]
    NCT06649955 | Controlling Amyotrophic Lateral Sclerosis Motor ...
    The MyoRegulator® treatment is a non-invasive intervention that suppresses motor neuron hyperexcitability and activates protein degradation pathways through the ...
  90. [90]
    Electrical nerve stimulation eases long COVID pain and fatigue
    Nov 25, 2024 · A wearable electrical nerve stimulation device can provide relief to people experiencing the persistent pain and fatigue linked to long COVID.
  91. [91]
    Physical Therapists' Use of Functional Electrical Stimulation for ...
    Functional electrical stimulation has been used in individuals with stroke to improve strength,4 upper extremity function,5 and gait6 and to prevent hemiplegic ...Missing: physiological | Show results with:physiological
  92. [92]
    Ethical considerations in closed loop deep brain stimulation
    Five main ethical issues to be considered include: analysis of risks and benefits, fair patient selection, protection of pediatric patients, respecting patients ...
  93. [93]
    Neuroprosthetics: from sensorimotor to cognitive disorders - Nature
    Jan 6, 2023 · Electrical neurostimulation can be used to induce movement as in motor neuroprostheses, but also to elicit somatic sensations such as touch or ...
  94. [94]
    A Personalized Multi-Channel FES Controller Based on Muscle ...
    Sep 15, 2016 · The aim of this study was to design a personalized multi-channel functional electrical stimulation (FES) controller for gait training, integrating three novel ...Missing: genomics | Show results with:genomics